Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights From DOSE-AHF and ROSE-AHF

Journal of Cardiac Failure

Volumn 22, Issue 11, 2016, Pages 884-890

  Grodin, Justin L ^a   Lala, Anuradha ^b,c   Stevens, Susanna R ^d   DeVore, Adam D ^d   Cooper, Lauren B ^d   AbouEzzeddine, Omar F ^e   Mentz, Robert J ^d   Groarke, John D ^b   Joyce, Emer ^b   Rosenthal, Julie L ^a   Vader, Justin M ^f   Tang, W H Wilson ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e MAYO CLINIC   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

diuretics; Heart failure; proteins

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; FUROSEMIDE; LOOP DIURETIC AGENT; NESIRITIDE; SERUM ALBUMIN; DIURETIC AGENT;

ACUTE HEART FAILURE; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DIURETIC THERAPY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; EMERGENCY WARD; FEMALE; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HYPOALBUMINEMIA; INCIDENCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE; WEIGHT CHANGE; ACUTE DISEASE; BLOOD; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; HOSPITAL MORTALITY; KIDNEY FAILURE; KIDNEY FUNCTION TEST; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; SURVIVAL ANALYSIS; UNITED STATES;

ACUTE DISEASE; AGED; BIOMARKERS; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; DIURETICS; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; KIDNEY FUNCTION TESTS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL INSUFFICIENCY; RISK ASSESSMENT; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84959276564     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2016.01.015     Document Type: Article

References (25)

1. 1 Quinlan, G.J., Martin, G.S., Evans, T.W., Albumin: biochemical properties and therapeutic potential. Hepatology 41 (2005), 1211–1219.
2. 2 Allen, L.A., Felker, G.M., Pocock, S., McMurray, J.J., Pfeffer, M.A., Swedberg, K., et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail 11 (2009), 170–177.
3. 3 Horwich, T.B., Kalantar-Zadeh, K., MacLellan, R.W., Fonarow, G.C., Albumin levels predict survival in patients with systolic heart failure. Am Heart J 155 (2008), 883–889.
4. 4 Arques, S., Roux, E., Sbragia, P., Gelisse, R., Pieri, B., Ambrosi, P., Usefulness of serum albumin concentration for in-hospital risk stratification in frail, elderly patients with acute heart failure. Insights from a prospective, monocenter study. Int J Cardiol 125 (2008), 265–267.
5. 5 Guyton, A.C., Lindsey, A.W., Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema. Circ Res 7 (1959), 649–657.
6. 6 Valdespino-Trejo, A., Orea-Tejeda, A., Castillo-Martinez, L., Keirns-Davis, C., Montanez-Orozco, A., Ortiz-Suarez, G., et al. Low albumin levels and high impedance ratio as risk factors for worsening kidney function during hospitalization of decompensated heart failure patients. Exp Clin Cardiol 18 (2013), 113–117.
7. 7 Clarke, M.M., Dorsch, M.P., Kim, S., Aaronson, K.D., Koelling, T.M., Bleske, B.E., Baseline albumin is associated with worsening renal function in patients with acute decompensated heart failure receiving continuous infusion loop diuretics. Pharmacotherapy 33 (2013), 583–588.
8. 8 Uthamalingam, S., Kandala, J., Daley, M., Patvardhan, E., Capodilupo, R., Moore, S.A., et al. Serum albumin and mortality in acutely decompensated heart failure. Am Heart J 160 (2010), 1149–1155.
9. 9 Felker, G.M., Lee, K.L., Bull, D.A., Redfield, M.M., Stevenson, L.W., Goldsmith, S.R., et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364 (2011), 797–805.
10. 10 Chen, H.H., Anstrom, K.J., Givertz, M.M., Stevenson, L.W., Semigran, M.J., Goldsmith, S.R., et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA 310 (2013), 2533–2543.
11. 11 Testani, J.M., Brisco, M.A., Turner, J.M., Spatz, E.S., Bellumkonda, L., Parikh, C.R., et al. Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail 7 (2014), 261–270.
12. 12 Witte, C.L., Witte, M.H., Dumont, A.E., Cole, W.R., Smith, J.R., Protein content in lymph and edema fluid in congestive heart failure. Circulation 40 (1969), 623–630.
13. 13 Drazner, M.H., Hellkamp, A.S., Leier, C.V., Shah, M.R., Miller, L.W., Russell, S.D., et al. Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial. Circ Heart Fail 1 (2008), 170–177.
14. 14 Breidthardt, T., Irfan, A., Klima, T., Drexler, B., Balmelli, C., Arenja, N., et al. Pathophysiology of lower extremity edema in acute heart failure revisited. Am J Med, 125, 2012 1124.e1–8.
15. 15 Damman, K., Testani, J.M., The kidney in heart failure: an update. Eur Heart J 36 (2015), 1437–1444.
16. 16 Torre-Amione, G., Milo-Cotter, O., Kaluski, E., Perchenet, L., Kobrin, I., Frey, A., et al. Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcome. J Card Fail 15 (2009), 639–644.
17. 17 Inoue, M., Okajima, K., Itoh, K., Ando, Y., Watanabe, N., Yasaka, T., et al. Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int 32 (1987), 198–203.
18. 18 Kitsios, G.D., Mascari, P., Ettunsi, R., Gray, A.W., Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a meta-analysis. J Crit Care 29 (2014), 253–259.
19. 19 Elwell, R.J., Spencer, A.P., Eisele, G., Combined furosemide and human albumin treatment for diuretic-resistant edema. Ann Pharmacother 37 (2003), 695–700.
20. 20 Chalasani, N., Gorski, J.C., Horlander, J.C. Sr, Craven, R., Hoen, H., Maya, J., et al. Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. J Am Soc Nephrol 12 (2001), 1010–1016.
21. 21 Bleske, B.E., Clark, M.M., Wu, A.H., Dorsch, M.P., The effect of continuous infusion loop diuretics in patients with acute decompensated heart failure with hypoalbuminemia. J Cardiovasc Pharmacol Ther 18 (2013), 334–337.
22. 22 Anand, I.S., Latini, R., Florea, V.G., Kuskowski, M.A., Rector, T., Masson, S., et al. C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 112 (2005), 1428–1434.
23. 23 Deswal, A., Petersen, N.J., Feldman, A.M., Young, J.B., White, B.G., Mann, D.L., Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone Trial (VEST). Circulation 103 (2001), 2055–2059.
24. 24 Carr, J.G., Stevenson, L.W., Walden, J.A., Heber, D., Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 63 (1989), 709–713.
25. 25 Anker, S.D., Ponikowski, P., Varney, S., Chua, T.P., Clark, A.L., Webb-Peploe, K.M., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349 (1997), 1050–1053.